Pro Medicus (Australia) Performance
| PME Stock | 230.00 2.36 1.04% |
On a scale of 0 to 100, Pro Medicus holds a performance score of 32. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pro Medicus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pro Medicus is expected to be smaller as well. Please check Pro Medicus' treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Pro Medicus' historical price patterns will revert.
Risk-Adjusted Performance
32 of 100
Weak | Strong |
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pro Medicus are ranked lower than 32 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Pro Medicus unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0019 | Payout Ratio 1.1604 | Forward Dividend Rate 0.44 | Ex Dividend Date 2024-09-04 |
1 | Pro Medicus And 2 Other High Growth Tech Stocks In Australia - Yahoo Finance | 09/18/2024 |
2 | A deep dive into PME shares - Rask Media | 09/30/2024 |
3 | Doubled in a year Does this booming ASX share have another 24 percent upside - MSN | 11/20/2024 |
| Begin Period Cash Flow | 91.2 M |
Pro |
Pro Medicus Relative Risk vs. Return Landscape
If you would invest 14,693 in Pro Medicus on August 29, 2024 and sell it today you would earn a total of 8,307 from holding Pro Medicus or generate 56.54% return on investment over 90 days. Pro Medicus is generating 0.7066% of daily returns assuming 1.7337% volatility of returns over the 90 days investment horizon. Simply put, 15% of all stocks have less volatile historical return distribution than Pro Medicus, and 86% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pro Medicus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pro Medicus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pro Medicus, and traders can use it to determine the average amount a Pro Medicus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.4075
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.73 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.41 actual daily | 32 68% of assets perform better |
Based on monthly moving average Pro Medicus is performing at about 32% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pro Medicus by adding it to a well-diversified portfolio.
Pro Medicus Fundamentals Growth
Pro Stock prices reflect investors' perceptions of the future prospects and financial health of Pro Medicus, and Pro Medicus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pro Stock performance.
| Return On Equity | 0.51 | ||||
| Return On Asset | 0.31 | ||||
| Profit Margin | 0.51 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 23.88 B | ||||
| Shares Outstanding | 104.5 M | ||||
| Price To Book | 128.03 X | ||||
| Price To Sales | 147.79 X | ||||
| Revenue | 161.5 M | ||||
| Gross Profit | 126.79 M | ||||
| EBITDA | 120.76 M | ||||
| Net Income | 82.79 M | ||||
| Total Debt | 2.07 M | ||||
| Book Value Per Share | 1.80 X | ||||
| Cash Flow From Operations | 86.78 M | ||||
| Earnings Per Share | 0.78 X | ||||
| Total Asset | 257.43 M | ||||
| Retained Earnings | 173.36 M | ||||
About Pro Medicus Performance
Assessing Pro Medicus' fundamental ratios provides investors with valuable insights into Pro Medicus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pro Medicus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Pro Medicus is entity of Australia. It is traded as Stock on AU exchange.Things to note about Pro Medicus performance evaluation
Checking the ongoing alerts about Pro Medicus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pro Medicus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pro Medicus is unlikely to experience financial distress in the next 2 years | |
| Pro is showing solid risk-adjusted performance over 90 days | |
| About 51.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Doubled in a year Does this booming ASX share have another 24 percent upside - MSN |
- Analyzing Pro Medicus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pro Medicus' stock is overvalued or undervalued compared to its peers.
- Examining Pro Medicus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pro Medicus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pro Medicus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pro Medicus' stock. These opinions can provide insight into Pro Medicus' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.